Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and Cancer: Reply to a Comment.

We thank Dr. Urata for his interest in our recent systematic review (1) and appreciate the opportunity to clarify two points he raised. First, the recommendations from the Brazilian Society of Rheumatology appear in two articles published in two different issues of the same journal: Rev Bras Reumatol 2012;52(2):135-174 and Rev Bras Reumatol 2013;53(2):158-183. In our review, these articles are cited as references 41 and 16, respectively. While both articles are from the same society, the information and content they each provide are slightly different.